Location: New York, NY
CIK: 0001831942 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value: $1.417B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | MERUS N V | 3,525,000 | $185M | 13.1% | $30.24 | — | COM | N5749R100 |
| NUVL | NUVALENT INC | 1,375,000 | $105M | 7.4% | $67.11 | +9.0% | COM | 670703107 |
| XENE | XENON PHARMACEUTICALS INC | 3,025,000 | $94.68M | 6.7% | $30.82 | +5.9% | COM | 98420N105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 4,692,809 | $94.14M | 6.6% | $19.08 | -0.8% | COM | 29337E102 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,325,000 | $77.33M | 5.5% | $33.00 | -8.2% | COM | 00847X104 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 3,450,000 | $70.21M | 5.0% | $22.13 | -12.1% | COM NEW | 15117B202 |
| ALKS | ALKERMES PLC | 2,450,000 | $70.09M | 4.9% | $26.49 | +12.3% | SHS | G01767105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 4,875,000 | $68.15M | 4.8% | $15.97 | -15.0% | COM | 92790C104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,075,000 | $59.42M | 4.2% | $47.99 | 0.0% | COM | 74366E102 |
| — | CIDARA THERAPEUTICS INC | 1,175,000 | $57.23M | 4.0% | $48.71 | — | COM NEW | 171757206 |
| SRRK | SCHOLAR ROCK HLDG CORP | 1,450,000 | $51.36M | 3.6% | $35.25 | -11.0% | COM | 80706P103 |
| SLNO | SOLENO THERAPEUTICS INC | 610,000 | $51.11M | 3.6% | $40.45 | +85.1% | COM | 834203309 |
| RLAY | RELAY THERAPEUTICS INC | 13,350,000 | $46.19M | 3.3% | $2.97 | 0.0% | COM | 75943R102 |
| NRIX | NURIX THERAPEUTICS INC | 3,948,653 | $44.98M | 3.2% | $21.29 | -49.2% | COM | 67080M103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 3,298,289 | $43.34M | 3.1% | $15.31 | — | SPONSORED ADS | 152309100 |
| PHVS | PHARVARIS N V | 1,911,433 | $33.64M | 2.4% | $23.20 | -30.5% | COM | N69605108 |
| KYMR | KYMERA THERAPEUTICS INC | 750,000 | $32.73M | 2.3% | $34.43 | 0.0% | COM | 501575104 |
| — | MIND MEDICINE MINDMED INC | 5,000,000 | $32.45M | 2.3% | $8.32 | — | COM NEW | 60255C885 |
| SYRE | SPYRE THERAPEUTICS INC | 1,988,084 | $29.76M | 2.1% | $14.79 | +0.1% | COM NEW | 00773J202 |
| TYRA | TYRA BIOSCIENCES INC | 3,100,000 | $29.67M | 2.1% | $10.56 | -10.0% | COM | 90240B106 |
| VERA | VERA THERAPEUTICS INC | 800,000 | $18.85M | 1.3% | $13.95 | +61.2% | CL A | 92337R101 |
| CTMX | CYTOMX THERAPEUTICS INC | 7,692,300 | $17.46M | 1.2% | $1.61 | 0.0% | COM | 23284F105 |
| COGT | COGENT BIOSCIENCES INC | 2,311,164 | $16.59M | 1.2% | $8.14 | -31.9% | COM | 19240Q201 |
| ORKA | ORUKA THERAPEUTICS INC | 1,419,714 | $15.91M | 1.1% | $34.43 | -69.7% | COM | 687604108 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 500,000 | $13.05M | 0.9% | $35.19 | -14.8% | COM NEW | 10919W405 |
| APGE | APOGEE THERAPEUTICS INC | 290,000 | $12.59M | 0.9% | $25.01 | +52.1% | COM | 03770N101 |
| IKT | INHIBIKASE THERAPEUTICS INC | 5,397,488 | $10.53M | 0.7% | $2.49 | -21.5% | COM NEW | 45719W205 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7.965M | 0.6% | $10.07 | +3.8% | CL A ORD SHS | G70077105 |
| TNGX | TANGO THERAPEUTICS INC | 1,500,000 | $7.68M | 0.5% | $2.47 | 0.0% | COM | 87583X109 |
| CBIO | CRESCENT BIOPHARMA INC. | 453,686 | $7.322M | 0.5% | $21.15 | 0.0% | COM | G2545C104 |
| NGNE | NEUROGENE INC | 427,866 | $6.397M | 0.5% | $33.71 | -53.4% | COM | 64135M105 |
| VTGN | VISTAGEN THERAPEUTICS INC | 1,575,000 | $3.15M | 0.2% | $4.44 | -48.8% | COM | 92840H400 |
| AVTX | AVALO THERAPEUTICS INC | 483,000 | $2.41M | 0.2% | $10.53 | -55.6% | COM NEW | 05338F306 |